10x Genomics (TXG) Net Income towards Common Stockholders Growth (3y) (2021 - 2026)

10x Genomics (TXG) Net Income towards Common Stockholders Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn 25.65%
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn 74.75%
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 156.91%
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn -14.58%
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn 35.73%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn -
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -16.63%
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn 40.29%
10 Teladoc Health 1.31 Bn 562.23 Mn 562.57 Mn 2.67%

Historic Data

Download Data
DateValue
Mar 31, 2026 35.73%
Dec 31, 2025 1.90%
Sep 30, 2025 13.14%
Jun 30, 2025 36.37%
Mar 31, 2025 6.78%
Dec 31, 2024 -38.51%
Sep 30, 2024 -27.69%
Jun 30, 2024 -50.80%
Mar 31, 2024 -73.14%
Dec 31, 2023 50.98%
Sep 30, 2023 -12.19%
Jun 30, 2023 -15.83%
Mar 31, 2023 -33.89%
Dec 31, 2022 -34.07%
Sep 30, 2022 -63.42%
Jun 30, 2022 -80.96%
Mar 31, 2022 -126.79%
Dec 31, 2021 37.49%
Sep 30, 2021 -3.82%